TLR4 and acute respiratory distress syndrome: Furthermore, various TLR4 antagonists are under development for indications like septic shock [49], suggesting that such strategies may effectively reduce ALI early in the course of the disease and TLR4 may also act as an important target in the development of clinical drug for ALI treatment.